Gilead Sciences, Inc. (GILD)

Gilead Sciences Revenue

Gilead Sciences had revenue of $7.55B in the quarter ending September 30, 2024, with 7.02% growth. This brings the company's revenue in the last twelve months to $28.30B, up 3.31% year-over-year. In the year 2023, Gilead Sciences had annual revenue of $27.12B, down -0.60%.

• Revenue (ttm): $28.30B
• Revenue Growth: +3.31%
• P/S Ratio: 4.10
• Revenue / Employee: $1,572,167
• Employees: 18,000
• Market Cap: 115.95B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	27.12B	-165.00M	-0.60%
Dec 31, 2022	27.28B	-24.00M	-0.09%
Dec 31, 2021	27.31B	2.62B	10.60%
Dec 31, 2020	24.69B	2.24B	9.98%
Dec 31, 2019	22.45B	322.00M	1.46%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.